Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof

Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof

US Patent 11566015 · Granted Jan 31, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Somatostatin subtype-2 receptor (SST2R) targeted therapeutics and uses thereof2024
Somatostatin subtype-2 receptor (SST2R) targeted therapeutics and uses thereof2024
Cannabinoid receptor modulators2024
Carrier also usable as wagon2024
Substituted tetrazolo[1,5-a]pyrazines and tetrazolo[1,5-c]pyrimidines as adenosi2024
Transgenic mouse for aglycosylated antibody production and use of aglycosylated 2024
Bond-selective intensity diffraction tomography and uses thereof2024
Somatostatin modulators and uses thereof2023
Somatostatin modulators and uses thereof2023
Somatostatin modulators and uses thereof2023
Method for extracting high-purity polydeoxyribonucleotide from salmon testes2023
Cannabinoid receptor modulators2023